Pharmaceutical

Image

Global Neuromuscular Blockade Drugs Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Neuromuscular Blockade Drugs Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 5.00 Billion
Diagram Market Size (Forecast Year) USD 7.11 Billion
Diagram CAGR %

Global Neuromuscular blockade Drugs Market, By Type (Depolarizing, Non-depolarizing, Others), DrugsSuccinylcholine, Cisatracurium, Mivacurium, Doxacurium, Rocuronium, Atracurium, Pancuronium, Vecuronium, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.

Neuromuscular Blockade Drugs Market Analysis and Size

Growing elderly populations worldwide who are more vulnerable to musculoskeletal disorders are the main factor driving the market growth. Neuromuscular blockades are powerful drugs, though these can have severe side effects such as heart failure, sedation, and paralysis. In many patients, sedation is witnessed as the common adverse effect. Consequently, physicians generally advise against driving or operating heavy machinery after neuromuscular blockade administration.

Data Bridge Market Research analyses a growth rate in the global neuromuscular blockade drugs market in the forecast period 2022-2029. The global neuromuscular blockade drug market's expected CAGR tends to be around 4.50% in the mentioned forecast period. The market was valued at USD 5 billion in 2022, and it would grow to USD 7.11 billion by 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Neuromuscular Blockade Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Depolarizing, Non-depolarizing, Others), Drugs (Succinylcholine, Cisatracurium, Mivacurium, Doxacurium, Rocuronium, Atracurium, Pancuronium, Vecuronium, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Sun Pharmaceutical Industries Ltd. (India), Merck & Co., Inc. (U.S.), Lilly (U.S.), Amgen Inc. (U.S.), Actelion Pharmaceuticals Ltd (Switzerland), Endo International plc (Ireland), Intas Pharmaceuticals Ltd. (India)

Market Opportunities

  • Increase in Elderly Population
  • Growing Prevalence of Lower Back Pain

Market Definition

Neuromuscular blocking agents or medications are the type of muscle relaxants that are widely used to prevent muscle contraction during surgery. They are structurally similar to acetylcholine and bring muscle relaxation by post-synaptic binding to acetylcholine receptors. Furthermore, when artificial ventilation is available, such agents should be used instead of anesthesia.

Global Neuromuscular Blockade Drugs Market Dynamics

Drivers

  • Growing Prevalence of Musculoskeletal Issues

The rising prevalence of musculoskeletal problems and increasing customer awareness of their treatment and management are raising the market's growth. Structurally distinct medications are the recent technologically improved neuromuscular blockades used to relax muscle spasms, discomfort, and hyperreflexia. This boosts the growth of the market.

  • Major Developments by the Market Players

There are numerous developments done by major market players that are boosting the growth of the market. For instance, in September 2019, Ipsen Biopharmaceuticals received U.S. FDA approval for expanded use of Dysport for injection to treat children two years of age and older having upper limb spasticity, excluding spasticity caused by cerebral palsy. Thus, this leads to market expansion.

Opportunities

  • Growing Elderly Population

Life expectancy is rising around the world, which has led to an increase in the aging population. This trend positively impacts the market by increasing the prevalence of the disease and creating per capita demand for its remedies. Thus, this set population demands high use of demyelinating disease therapeutics and, in return, creates more opportunities for market growth.

According to the records of the World Health Organization (WHO), the non-specific burden of lower back pain has increased significantly globally, which is projected at 60–70% in industrialized countries, whereas one-year incidence increased rate 15–45%, adult prevalence 5% per annum and mostly incidence of lower back pain has seen in above 35 age bracket people. Thus, this factor demands more drugs and, as a result, is increasing the market's growth.

Restraints/Challenges

  • Adverse Side-Effects of Neuromuscular blockades

There are severe side effects that are linked with neuromuscular blockades, such as dry mouth, tiredness, dizziness, and depression which restrict the market growth.

  • High Investment and Strict Regulatory Norms

The growth of the neuromuscular blockade drug market is limited by factors such as strict regulatory requirements and the risks related to neuromuscular blockades. The use, separation, and development of raw materials for the development of pharmaceutical and biopharmaceutical drugs demand professional and qualified personnel. Thus, all these factors restrict the growth of the demand for neuromuscular blockade drugs.

This global neuromuscular blockade drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global neuromuscular blockade drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Neuromuscular Blockade Drugs Market

Musculoskeletal pain is observed to be a common problem in routine medical practice. Many pain sources are associated with muscles or fascia becoming damaged, which then triggers pain. Although COVID-19 primarily affects the lungs and internal organs, musculoskeletal injury from this disease was visible because of the marked elevation in creatine kinase and lactate dehydrogenase levels. Moreover, pain management during the COVID-19 pandemic demands attention because of difficulties accessing hospitals for medical services such as physical therapy and rehabilitation. Thus, COVID-19 greatly impacted the global neuromuscular blockade drugs market.

Global Neuromuscular Blockade Drugs Market Scope

The global neuromuscular blockade drugs market is segmented on the basis of type, drugs, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Depolarizing
  • Non-depolarizing
  • Others

Drugs

  • Succinylcholine
  • Cisatracurium
  • Mivacurium
  • Doxacurium
  • Rocuronium
  • Atracurium
  • Pancuronium
  • Vecuronium
  • Others

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Neuromuscular Blockade Drugs Market Regional Analysis/Insights

The global neuromuscular blockade drugs market is analysed and market size insights and trends are provided by type, drugs,end-user, distribution channel as referenced above.

The major countries covered in the global neuromuscular blockade drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is considered to have the highest lucrative growth in the forecast period due to the region's increased R&D activities on muscle relaxants and well-established healthcare infrastructure. 

Asia-Pacific is dominating the market due to increased advancement in technology, and the huge development of novel molecules for the treatment of pain and spasms

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Neuromuscular Blockade Drugs Market Share Analysis

The global neuromuscular blockade drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global neuromuscular blockade drugs market.

Key players operating in the global neuromuscular blockade drugs market include:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Private Limited (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Merck & Co., Inc. (U.S.)
  • Lilly (U.S.)
  • Amgen Inc. (U.S.)
  • Actelion Pharmaceuticals Ltd (Switzerland
  • Endo International plc (Ireland)
  • Intas Pharmaceuticals Ltd. (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global neuromuscular blockade drugs market was USD 5 billion in 2022.
The global neuromuscular blockade drugs market is projected to grow at a CAGR of 4.50% during the forecast period of 2023-2030.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials